Research ArticleHEAD & NECK
Imaging Findings of Bisphosphonate-Associated Osteonecrosis of the Jaws
P.M. Phal, R.W.T. Myall, L.A. Assael and J.L. Weissman
American Journal of Neuroradiology June 2007, 28 (6) 1139-1145; DOI: https://doi.org/10.3174/ajnr.A0518
P.M. Phal
R.W.T. Myall
L.A. Assael

References
- ↵Sparidans RW, Twiss IM, Talbot S. Bisphosphonates in bone diseases. Pharm World Sci 1998;20:206–13
- ↵Marx RE. Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic. J Oral Maxillofac Surg 2003;61:1115–17
- ↵Ruggiero SL, Mehrotra B, Rosenberg TJ, et al. Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases. J Oral Maxillofac Surg 2004;62:527–34
- ↵Marx RE, Sawatari Y, Fortin M, et al. Bisphosphonate-induced exposed bone (osteonecrosis/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment. J Oral Maxillofac Surg 2005;63:1567–75
- Migliorati CA, Schubert MM, Peterson DE, et al. Bisphosphonate-associated osteonecrosis of mandibular and maxillary bone: an emerging oral complication of supportive cancer therapy. Cancer 2005;104:83–93
- Bagan JV, Murillo J, Jimenez Y, et al. Avascular jaw osteonecrosis in association with cancer chemotherapy: series of 10 cases. J Oral Pathol Med 2005;34:120–23
- ↵Carneiro E, Vibhute P, Montazem A, et al. Bisphosphonate-associated mandibular osteonecrosis. AJNR Am J Neuroradiol 2006;27:1096–97
- ↵Kolata G. Drug for bones is linked to jaw disease. New York Times June 2,2006;sect A:1
- ↵Novartis. Expert Panel Recommendation for the Prevention, Diagnosis and Treatment of Osteonecrosis of the Jaw. East Hanover, NJ: Novartis;2005 . Available at: http://www.fda.gov/OHRMS/DOCKETS/AC/05/briefing/20054095B2_02_12-Novartis-Zometa-App-11.pdf
- ↵Tolar J, Teitelbaum SL, Orchard PJ. Osteopetrosis. N Engl J Med 2004;351:2839–49
- ↵Reszka AA, Rodan GA. Mechanism of action of bisphosphonates. Curr Osteoporos Rep 2003;1:45–52
- ↵Reszka AA, Rodan GA. Nitrogen-containing bisphosphonate mechanism of action. Mini Rev Med Chem 2004;4:711–19
- ↵Hellstein JW, Marek CL. Bisphosphonate osteochemonecrosis (bis-phossy jaw): is this phossy jaw of the 21st century? J Oral Maxillofac Surg 2005;63:682–89
- ↵Whyte MP, Wenkert D, Clements KL, et al. Bisphosphonate-induced osteopetrosis. N Engl J Med 2003;349:457–63
- ↵Junquera L, Rodriguez-Recio C, Villarreal P, et al. Autosomal dominant osteopetrosis and maxillomandibular osteomyelitis. Am J Otolaryngol 2005;26:275–78
- ↵Batra P, Shah N. Recalcitrant osteomyelitis following tooth extraction in a case of malignant osteopetrosis. Int Dent J 2004;54:418–23
- ↵Wood J, Bonjean K, Ruetz S, et al. Novel antiangiogenic effects of the bisphosphonate compound zoledronic acid. J Pharmacol Exp Ther 2002;302:1055–61
- ↵Fournier P, Boissier S, Filleur S, et al. Bisphosphonates inhibit angiogenesis in vitro and testosterone-stimulated vascular regrowth in the ventral prostate in castrated rats. Cancer Res 2002;62:6538–44
- ↵Miesse AM, Willey JS, Bateman TA. Potential role of proinflammatory cytokines in nerve damage related bone loss. Biomed Sci Instrum 2004;40:266–71
- ↵Donoghue AM. Bisphosphonates and osteonecrosis: analogy to phossy jaw. Med J Aust 2005;183:163–64
- ↵Miles AE. Phosphorus necrosis of the jaw: ‘phossy jaw’. Br Dent J 1972;133:203–06
- ↵Seeman E, Delmas PD. Bone quality–the material and structural basis of bone strength and fragility. N Engl J Med 2006;354:2250–61
- ↵Polizzotto MN, Cousins V, Schwarer AP. Bisphosphonate-associated osteonecrosis of the auditory canal. Br J Haematol 2006;132:114
- ↵White S, Pharoah M. Oral Radiology, Principles and Interpretation, 4th ed. St. Louis: Mosby;2000
- ↵Ruggiero SL. Bisphosphonate-induced osteonecrosis: OMS perspective. Paper presented at: Meeting of the American Association of Oral Maxillofacial Surgeons,2005; Boston, September 20-25, 2005
- ↵Chiandussi S, Biasotto M, Dore F, et al. Clinical and diagnostic imaging of bisphosphonate-associated osteonecrosis of the jaws. Dentomaxillofac Radiol 2006;35:236–43
- ↵
- ↵Orpe EC, Lee L, Pharoah MJ. A radiological analysis of chronic sclerosing osteomyelitis of the mandible. Dentomaxillofac Radiol 1996;25:125–29
- ↵Resnick D, Kransdorf M. Bone and Joint Imaging, 3rd ed. Philadelphia: Elsevier Saunders;2005
- ↵van der Waal RI, Buter J, van der Waal I. Oral metastases: report of 24 cases. Br J Oral Maxillofac Surg 2003;41:3–6
In this issue
Advertisement
Imaging Findings of Bisphosphonate-Associated Osteonecrosis of the Jaws
P.M. Phal, R.W.T. Myall, L.A. Assael, J.L. Weissman
American Journal of Neuroradiology Jun 2007, 28 (6) 1139-1145; DOI: 10.3174/ajnr.A0518
Jump to section
Related Articles
- No related articles found.
Cited By...
- Suspected bisphosphate-related osteonecrosis of the jaw in a cat being treated with alendronate for idiopathic hypercalcaemia
- A retrospective study of digital subtraction technique to detect sclerotic changes in alveolar bone on intraoral radiographs of bisphosphonate-treated patients
- Incidence of Bisphosphonate-related Osteonecrosis of the Jaw in Consideration of Primary Diseases and Concomitant Therapies
- Fractal dimension evaluation of cone beam computed tomography in patients with bisphosphonate-associated osteonecrosis
- Osteonecrosis of the jaw: a rare and devastating side effect of bisphosphonates
- Bisphosphonate Associated Osteonecrosis of the Jaw
This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.
More in this TOC Section
Similar Articles
Advertisement